Conventional Hypoglycaemic Agents and the Risk of Lung Cancer in Patients with Diabetes: A Meta-Analysis

BACKGROUND: Accumulating evidence suggests that hypoglycaemic agents influence lung cancer risk in patients with diabetes. It remains to be fully elucidated whether conventional hypoglycaemic agents (metformin, sulfonylureas, thiazolidinediones [TZDs] or insulin) affect lung cancer incidence in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ying, Liu, Hong-Bing, Shi, Xue-Fei, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055722/
https://www.ncbi.nlm.nih.gov/pubmed/24924771
http://dx.doi.org/10.1371/journal.pone.0099577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055722/
https://www.ncbi.nlm.nih.gov/pubmed/24924771
http://dx.doi.org/10.1371/journal.pone.0099577

Ejemplares similares